Epidemiological and Clinical Profile of Covid-19 in Pregnant Women and Newborns
Alex Patrick Oliveira da Silva
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Sebastião Kauã de Sousa Bispo
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Karoline Guerreiro Sales da Cunha
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Maísa Barroso de Araújo
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Brenda Tereza Freitas Viana
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Lucas de Sousa Miranda
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Marina Rodrigues Andrade Costa
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Giselly do Socorro Santos de Oliveira
Universidade da Amazônia (UNAMA). Ananindeua, Pará, Brazil.
Daniele Melo Sardinha *
Programa de Pós-Graduação em Biologia Parasitária na Amazônia, Universidade do Estado do Para e Instituto Evandro Chagas (PPGBPA/UEPA/IEC). Belém, Pará, Brazil.
Tamires de Nazaré Soares
Programa de Pós-Graduação em Biologia Parasitária na Amazônia, Universidade do Estado do Para e Instituto Evandro Chagas (PPGBPA/UEPA/IEC). Belém, Pará, Brazil.
*Author to whom correspondence should be addressed.
Abstract
COVID-19 is a respiratory disease. In around 85% of cases, it presents as flu-like symptoms, including fever, cough, sore throat, myalgia, adynamia, runny nose, and loss of smell and taste. However, approximately 15% of cases can progress to a severe form of the disease. Since the first reported case of neonatal COVID-19 in February 2020, concerns have been raised about the possibility of vertical transmission of SARS-CoV-2. The initial Chinese reports suggested that vertical transmission of SARS-CoV-2 does not occur. Samples of amniotic fluid, vaginal mucus, placenta, umbilical cord, cord blood and neonatal feces were negative for the virus. Understanding the possible routes of transmission from mother to newborn is crucial for preventing potential neonatal infections and developing appropriate guidelines for neonatal care. This study aims to describe the epidemiological and clinical profile of pregnant women and newborns with COVID-19, based on a narrative review of the literature. The epidemiological and clinical characteristics of COVID-19 in pregnant women and newborns are primarily respiratory symptoms such as discomfort, dyspnea, and fever. Studies have shown that lethality and incidence are low in newborns without comorbidities, but high in mothers. Breastfeeding and rooming-in are recommended according to guidelines and published studies, with appropriate precautions taken. It is important to maintain objectivity and avoid biased language when discussing these findings.
Keywords: Newborn, neonatal, pregnant woman, severe acute respiratory syndrome, COVID-19